Overall, the findings of our study indicate that ginseng compounds, due to their significant ACE and CA-I inhibitory potential, favorable safety profiles, and promising pharmacokinetic properties, could serve as viable alternatives to synthetic drugs for hypertension treatment. The gene discussed is CA1; the disease is Hypertension.